| Literature DB >> 28042561 |
Chami Im1, Hyung Sub Park1, Dae Hwan Kim1, Taeseung Lee1.
Abstract
Spontaneous renal artery dissection (SRAD) is a rare disease entity. The diagnosis is usually delayed because clinical presentation is non-specific. We report three cases of symptomatic SRAD complicated by renal infarction which occurred in previously healthy middle-aged male patients. They visited the hospital due to acute abdominal or flank pain. They had no specific underlying disease or trauma history. The laboratory tests and physical examination were normal. They were not suspected of having SRAD initially, but computed tomography (CT) revealed dissection of the renal artery with distal hypoperfusion leading to renal infarction. They were treated conservatively with anticoagulation and/or antiplatelets for 6 months. They had a 6-month regular follow-up with CT, where resolution was confirmed in one patient and all patients remained asymptomatic. These cases emphasize the importance of clinical suspicion of SRAD in previously healthy patients who complain of abdominal pain without specific findings on initial investigation.Entities:
Keywords: Dissection; Endovascular procedures; Infarction; Kidney; Renal artery
Year: 2016 PMID: 28042561 PMCID: PMC5198768 DOI: 10.5758/vsi.2016.32.4.195
Source DB: PubMed Journal: Vasc Specialist Int ISSN: 2288-7970
Fig. 1.Case 1. CT scan demonstrated circumferential wall thickening of the left mid to distal renal artery with thrombus and wedge-shaped perfusion defect at the left kidney lower pole posterolateral aspect.
Fig. 2.Case 2. (A) CT scan disclosed a focal dissection at the right distal renal artery with infarction. (B) Eighteen months later, CT scan showed old renal infarction sequelae in the right kidney with disappearance of thrombus in the left renal artery and no evidence of perfusion defect.
Fig. 3.Case 3. Left renal infarcts associated with left renal artery dissection were identified on CT.
Fig. 4.Treatment algorithm for SRAD. SRAD, spontaneous renal artery dissection; ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blockers; CCB, calcium channel blockers; LMWH, low-molecular-weight heparins.